Unrecognized Tax Benefits of Outlook Therapeutics, Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Outlook Therapeutics, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Outlook Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending 30 Sep 2025 was $300,000, a 84% decline year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Outlook Therapeutics, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $300,000 -$1,554,629 -84% 30 Sep 2025 10-K 19 Dec 2025 2025 FY
Q3 2024 $1,854,629 $0 0% 30 Sep 2024 10-K 19 Dec 2025 2025 FY
Q3 2023 $1,854,629 -$2,000 -0.11% 30 Sep 2023 10-K 19 Dec 2025 2025 FY
Q3 2022 $1,856,629 $0 0% 30 Sep 2022 10-K 27 Dec 2024 2024 FY
Q3 2021 $1,856,629 $0 0% 30 Sep 2021 10-K 22 Dec 2023 2023 FY
Q3 2020 $1,856,629 -$2,805 -0.15% 30 Sep 2020 10-K 29 Dec 2022 2022 FY
Q3 2019 $1,859,434 +$3,305 +0.18% 30 Sep 2019 10-K 23 Dec 2021 2021 FY
Q3 2018 $1,856,129 -$496,000 -21% 30 Sep 2018 10-K 23 Dec 2020 2020 FY
Q3 2017 $2,352,129 +$497,500 +27% 30 Sep 2017 10-K 19 Dec 2019 2019 FY
Q3 2016 $1,854,629 +$100,000 +5.7% 30 Sep 2016 10-K 18 Dec 2018 2018 FY
Q3 2015 $1,754,629 +$190,218 +12% 30 Sep 2015 10-K 29 Dec 2017 2017 FY
Q3 2014 $1,564,411 30 Sep 2014 10-K 29 Dec 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.